PhenoCHEST: PhenoCHEST - Rapid CT Screening for COVID-19

by Digital Health

Rapid screening & efficient triaging via AI enabled imaging. Providers benefit from automated workflow. Results in minutes vs. lengthy (3-10 day) reporting of results from (limited) PCR testing.
New York, NY United States COVID-19 AI in Medicine WarOnCOVID challenge

All Team Company Mission Innovation Details Supporters Comments Updates

About our project

The problem we solve: In response to the ongoing global COVID-19 pandemic, PhenoMx has created the PhenoCHEST (TM) rapid CT screening protocol. This new tool leverages non-invasive CT scanning, digital chest X-Rays and start-of-the-art Artificial Intelligence algorithms to rapidly score findings and characteristics associated with the presence of COVID-19. PhenoCHEST (TM) has been developed using a limited real-world data set from patients infected with COVID-19 in both China and South Korea.

About our solution: Our image processing platform helps screen & triage suspected cases from the time of onset of symptoms to the reporting of results from PCT testing, limiting the exposure and transmission to other people. For example, when a patient develops fever, cough, etc, they can be arrive at an imaging facility, even separate from the hospital, to be scanned and receive a result in under 2 minutes, compared with arriving at a crowded ER/Urgent Care facility with the possibility of infecting or becoming infected via other while waiting for a PCR test, and then waiting days for a result. During the crisis in China they were scanning on average 200 people per day per scanner (approx every 5-7 minutes).

Progress to date:

Dialogue with FDA & FEMA yesterday and the Spanish Government today. Currently involved in a clinical trial in Korea (executed data sharing agreement, IRB submission, protocol, and MOU). In discussions with Germany, India, Italy, Spain, Thailand, UAE, and USA.

About Our Team

Creator: Digital Health

Location: New York

Bio: We Improve Lives, Transforming Medicine Along the Way

Title: PhenoMx

Advanced Degree(s): MD

About Our Company

PhenoMx

Location: 105 E 34TH ST
New York, NY 10016

Founded: 2017

Website: http://www.phenomx.co

Twitter: @PhenoMxInc

Product Stage: Ready

Employees: 5-10

Innovation Details

Intellectual Property Summary

The PhenoCHEST solution contains proprietary image processing algorithms that have not yet been patented but will remain undisclosed. 

Clinical Information

PhenoCHEST is based on clinical images derived from equipment that has been cleared by respective regulatory authorities and government notified bodies. This tool is being provided to healthcare systems and clinicians on an investigational basis. 

Regulatory Status

PhenoCHEST is based on clinical images derived from equipment that has been cleared by respective regulatory authorities and government notified bodies. This tool is being provided to healthcare systems and clinicians on an investigational basis. Application for FDA Approval would be under consideration with funds raised. 

How we will use the funds raised

Funding and grants obtained through this effort will accelerate our go-to-market strategy and can support ongoing product development and regulatory efforts. 

Thank You

We are a team of biomedical engineers and medical doctors with over 20 years of experience managing global multi-center clinical trial specifically for quantitative imaging. Our backgrounds in AI, imaging processing & hardware, healthcare administration, and medical device position us well to contribute to the ongoing battle against the coronavirus pandemic. We are seeking your support to provide PhenoCHEST to healthcare systems around the globe. 

Supporters

Comments

    No comments found .

Login to post your comment!
Click here to Login

Updates

    No updates found .

6
Medstartr
Index Score

6

Interest
Score

0

Adoption
Score
  • 4 Days left

$ 500,000 goal



Rewards